Schwannomatosis, sporadic schwannomatosis, and familial schwannomatosis: a surgical series with long-term follow-up

Clinical article

Restricted access

Object

The aim of this study was to provide disease-specific information about schwannomatosis in its different forms and to present 2 particular cases of malignant schwannomas in the context of familial schwannomatosis (FS).

Methods

The authors analyzed patients with pathologically defined schwannomas and identified those with varied forms of schwannomatosis. Each case was retrospectively analyzed for patient sex and age, number of operations and tumors excised, symptoms, location and size of tumors, extent of resection, nerve function pre- and postoperatively, complications, other nonsurgically treated tumors, malignancy, results of brain MR imaging, and follow-up data.

Results

One hundred fifty-eight patients underwent the excision of 216 schwannomas. One hundred forty-two patients presented with solitary schwannomas, 2 had neurofibromatosis Type 2 (NF2), and 14 presented with schwannomatosis. The average follow-up was 52 months. Six individuals had sporadic schwannomatosis, whereas 8 had the familial form of the disease. These 14 patients had an average age of 28.3 years at the time of disease onset (median 27.5 years) and 35.4 years at the time of the first operation (median 37 years) Thirteen of the 14 patients with schwannomatosis experienced pain as the first symptom. Eight (57%) of the 14 patients presented with at least 1 tumor in the spinal canal or attached to the spinal nerve roots. Malignant schwannomas developed in 2 patients from the same family during the follow-up.

Conclusions

Patients suffering from schwannomatosis tend to be younger than those presenting with solitary schwannomas. Therefore, individuals presenting at a young age with multiple schwannomas but not meeting the criteria for NF2 should prompt the physician to suspect schwannomatosis. Patients with schwannomatosis who report pain should be exhaustively examined. The spine is affected in the majority of patients, and MR imaging of the spine should be part of the routine evaluation. Rapid enlargement of schwannomas in the context of FS should raise suspicion of malignant transformation.

Abbreviations used in this paper: FS = familial schwannomatosis; NF2 = neurofibromatosis Type 2; SS = sporadic schwannomatosis.

Article Information

Address correspondence to: Augusto Gonzalvo, M.D., 11/19 Coolidge Wynd, Macleod, VIC, 3085, Australia. email: augusto.gonzalvo@gmail.com.

Please include this information when citing this paper: published online October 8, 2010; DOI: 10.3171/2010.8.JNS091900.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Pedigrees of the 4 families studied. Arrows indicate probands; squares, males; and circles, females.

References

1

Antinheimo JSankila RCarpén OPukkala ESainio MJääskeläinen J: Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71762000

2

Bacci CSestini RProvenzano APaganini IMancini IPorfirio B: Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics 11:73802010

3

Baser MEFriedman JMEvans DG: Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology 66:7307322006

4

Bhattacharyya AKPerrin RGuha A: Peripheral nerve tumors: management strategies and molecular insights. J Neurooncol 69:3353492004

5

Boyd CSmith MJKluwe LBalogh AMaccollin MPlotkin SR: Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:3583662008

6

Buckley PGMantripragada KKDíaz de Ståhl TPiotrowski AHansson CMKiss H: Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2. Hum Mutat 26:5405492005

7

Evans DGMason SHuson SMPonder MHarding AEStrachan T: Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry 62:3613661997

8

Hadfield KDNewman WGBowers NLWallace ABolger CAColley A: Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet 45:3323392008

9

Huang JHSimon SLNagpal SNelson PTZager EL: Management of patients with schwannomatosis: report of six cases and review of the literature. Surg Neurol 62:3533612004

10

Hulsebos TJMKenter SBJakobs MEBaas FChong BDelatycki MB: SMARCB1/INI1 maternal germ line mosaicism in schwannomatosis. Clin Genet 77:86912010

11

Hulsebos TJMPlomp ASWolterman RARobanus-Maandag ECBaas FWesseling P: Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:8058102007

12

Jacoby LBJones DDavis KKronn DShort MPGusella J: Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis. Am J Hum Genet 61:129313021997

13

Javalkar VKPigott TPal PFindlay G: Multiple schwannomas: report of two cases. Eur Spine J 16:Suppl 32872922007

14

Leverkus MKluwe LRöll EMBecker GBröcker EBMautner VF: Multiple unilateral schwannomas: segmental neurofibromatosis type 2 or schwannomatosis?. Br J Dermatol 148:8048092003

15

MacCollin MChiocca EAEvans DGFriedman JMHorvitz RJaramillo D: Diagnostic criteria for schwannomatosis. Neurology 64:183818452005

16

MacCollin MWillett CHeinrich BJacoby LBAcierno JS JrPerry A: Familial schwannomatosis: exclusion of the NF2 locus as the germline event. Neurology 60:196819742003

17

MacCollin MWoodfin WKronn DShort MP: Schwannomatosis: a clinical and pathologic study. Neurology 46:107210791996

18

Ogose AHotta TMorita TOtsuka HHirata Y: Multiple schwannomas in the peripheral nerves. J Bone Joint Surg Br 80:6576611998

19

Patil SPerry AMaccollin MDong SBetensky RAYeh TH: Immunohistochemical analysis supports a role for INI1/SMARCB1 in hereditary forms of schwannomas, but not in solitary, sporadic schwannomas. Brain Pathol 18:5175192008

20

Seppälä MTSainio MAHaltia MJKinnunen JJSetälä KHJääskeläinen JE: Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?. J Neurosurg 89:36411998

21

Sestini RBacci CProvenzano AGenuardi MPapi L: Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 29:2272312008

22

Westhout FDMathews MParé LSArmstrong WBTully PLinskey ME: Recognizing schwannomatosis and distinguishing it from neurofibromatosis type 1 or 2. J Spinal Disord Tech 20:3293322007

TrendMD

Cited By

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 108 108 45
Full Text Views 157 157 6
PDF Downloads 60 60 7
EPUB Downloads 0 0 0

PubMed

Google Scholar